What is it about?
Delayed treatment with the human protein plasma gelsolin improves survival of mice with severe influenza.
Featured Image
Why is it important?
There are no drugs for severe influenza, and the improved outcome with plasma gelsolin makes it a good candidate for further development for possible use in human patients.
Read the Original
This page is a summary of: Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza, F1000Research, November 2019, Faculty of 1000, Ltd.,
DOI: 10.12688/f1000research.21082.1.
You can read the full text:
Contributors
The following have contributed to this page
